Caplin Point Laboratories Limited (BOM:524742)
India · Delayed Price · Currency is INR 2,300.20
-2.85 (-0.12%)
At close: Oct 16, 2026
Caplin Point Laboratories Market Cap
Caplin Point Laboratories has a market cap or net worth of 174.84 billion as of October 16, 2026. It is the 6,986th most valuable company in the world and the 405th biggest in India. Its market cap has increased by 14.13% in one year.
Market Cap
174.84B
Enterprise Value
166.01B
Revenue
22.87B
Global Rank
Country Rank
#405 India
PE Ratio
26.35
ChartMarket Cap Chart
Since February 26, 2002, Caplin Point Laboratories's market cap has increased from 5.60M to 174.84B, an increase of 3,122,638.04%. That is a compound annual growth rate of 52.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 174.84B | 24.93% |
| Dec 31, 2025 | 139.95B | -26.39% |
| Dec 31, 2024 | 190.12B | 84.60% |
| Dec 29, 2023 | 102.99B | 90.47% |
| Dec 30, 2022 | 54.07B | -16.82% |
| Dec 31, 2021 | 65.01B | 69.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pharmaceuticals | 434.56B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 204.61B |
| Jubilant Pharmova | 149.58B |
| AstraZeneca Pharma India | 149.15B |
| Viyash Scientific | 98.66B |
| Procter & Gamble Health | 86.41B |
| Bliss GVS Pharma | 70.05B |